ReviewFrontiers in endocrinology2020

The Effects of DPP-4 Inhibitors, GLP-1RAs, and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism.

Xiaohui Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.